Ani Pharmaceuticals (ANIP) Treasury Shares (2013 - 2026)
Ani Pharmaceuticals (ANIP) posted Treasury Shares of $53.0 million for Q1 2026, up 59.42% sequentially from $33.2 million in Q4 2025, and up 70.74% YoY from $31.0 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Treasury Shares (2013 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Treasury Shares for 13 years, with the latest figure at $53.0 million in Q1 2026.
- Quarterly Treasury Shares rose 70.74% year-over-year to $53.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.0 million (up 70.74% YoY) and the FY2025 annual result came in at $33.2 million, up 58.03% from the prior year.
- Treasury Shares advanced to $53.0 million in Q1 2026 per ANIP's latest filing, from $33.2 million in the prior quarter.
- Over five years, Treasury Shares peaked at $1.4 million in Q1 2023 and troughed at $25000.0 in Q1 2024.
- A 5-year average of $689397.5 and a median of $613972.0 in 2025 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 256.82% in 2025, down 58.03% in 2025.
- Over 5 years, Treasury Shares stood at $5.1 million in 2022, then jumped by 97.9% to $10.1 million in 2023, then surged by 108.71% to $21.0 million in 2024, then soared by 58.03% to $33.2 million in 2025, then jumped by 59.42% to $53.0 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $53.0 million, $33.2 million, and $32.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 19.00 Mn |
| 10 | Ani Pharmaceuticals | 1.58 Bn | 1.22 Bn | 165.89 Mn | 891,915.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.54 Mn |
| Jun 30, 2026 | 53.82 Mn |
| Jun 30, 2026 | 53.82 Mn |
| Jun 30, 2026 | 1.54 Mn |
| Mar 31, 2026 | 53.00 Mn |
| Mar 31, 2026 | 53.00 Mn |
| Mar 31, 2026 | 881,490.00 |
| Mar 31, 2026 | 881,490.00 |
| Dec 31, 2025 | 621,296.00 |
| Dec 31, 2025 | 621,296.00 |
| Dec 31, 2025 | 33.25 Mn |
| Dec 31, 2025 | 33.25 Mn |
| Sep 30, 2025 | 32.64 Mn |
| Sep 30, 2025 | 613,972.00 |
| Sep 30, 2025 | 613,972.00 |
| Sep 30, 2025 | 32.64 Mn |
| Jun 30, 2025 | 602,000.00 |
| Jun 30, 2025 | 602,000.00 |
| Jun 30, 2025 | 31.59 Mn |
| Jun 30, 2025 | 31.59 Mn |